Nipro Corp. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
12,891
19,908
26,284
18,324
17,026
21,233
Depreciation, Depletion & Amortization
29,978
33,060
33,833
34,035
35,996
38,624
Other Funds
18
20
1,621
2,132
76
6,590
Funds from Operations
29,424
32,238
43,584
52,115
47,711
53,267
Changes in Working Capital
7,872
4,257
13,650
18,643
6,665
11,905
Net Operating Cash Flow
21,552
27,981
29,934
33,472
41,046
41,362
Capital Expenditures
29,239
40,680
41,936
64,224
62,656
Sale of Fixed Assets & Businesses
360
3,752
22,468
409
655
Purchase/Sale of Investments
2,778
9,145
3,333
317
8,392
Net Investing Cash Flow
31,936
29,713
16,513
66,351
64,140
Cash Dividends Paid - Total
5,038
4,987
5,362
4,072
6,484
Issuance/Reduction of Debt, Net
5,642
31,393
3,151
47,462
53,685
Net Financing Cash Flow
16,346
26,598
3,633
36,483
47,341
Net Change in Cash
21,749
26,651
13,004
169
23,552
Free Cash Flow
7,687
12,699
12,002
30,752
21,610
Net Assets from Acquisitions
6,958
2,154
-
3,837
11,928
Other Sources
1,311
376
2,172
1,693
2,155
Change in Capital Stock
16,932
212
199
4,774
218
Exchange Rate Effect
4,981
1,785
3,216
3,773
695
Other Uses
188
152
2,550
74
756

About Nipro

View Profile
Address
3-9-3 Honjo-Nishi
Osaka Osaka 531
Japan
Employees -
Website http://www.nipro.co.jp
Updated 07/08/2019
Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. Its operations are carried out through the following segments: Medical related, Pharmaceutical related, Pharma Packaging, and Others. The Medical related segment provides injection and infusion-related products, artificial organ-related products, functional products, and dialysis and diabetes-related products.